BioCardia BCDAW Stock
BioCardia Price Chart
BioCardia BCDAW Financial and Trading Overview
| BioCardia stock price | 0.0061 USD |
| Previous Close | 0.0063 USD |
| Open | 0.0062 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0061 - 0.0063 USD |
| 52 Week Range | 0.0061 - 0.0063 USD |
| Volume | 18.71K USD |
| Avg. Volume | N/A |
| Market Cap | N/A |
| Beta (5Y Monthly) | 1.365 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.2 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BCDAW Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
BioCardia Stock Price History
| Beta (5Y Monthly) | 1.365 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | 27.18% |
| 52 Week High | 0.0063 USD |
| 52 Week Low | 0.0061 USD |
| 50-Day Moving Average | N/A |
| 200-Day Moving Average | N/A |
BCDAW Share Statistics
| Avg. Volume (3 month) | N/A |
| Avg. Daily Volume (10-Days) | N/A |
| Shares Outstanding | N/A |
| Float | 1.21M |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -4136.36% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -132.67% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 468K USD |
| Revenue Per Share (ttm) | 0.31 USD |
| Quarterly Revenue Growth (yoy) | -14.099% |
| Gross Profit (ttm) | -6115000 USD |
| EBITDA | -10328000 USD |
| Net Income Avi to Common (ttm) | -10337000 USD |
| Diluted EPS (ttm) | -3.2 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 949K USD |
| Total Cash Per Share (mrq) | 0.52 USD |
| Total Debt (mrq) | 1.23M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.309 |
| Book Value Per Share (mrq) | -1.272 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -8944000 USD |
| Levered Free Cash Flow (ttm) | -5295625 USD |
Profile of BioCardia
| Country | United States |
| State | CA |
| City | Sunnyvale |
| Address | 320 Soquel Way |
| ZIP | 94085 |
| Phone | 650 226 0120 |
| Website | https://www.biocardia.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 16 |
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. Its lead product candidate is CardiAMP, an autologous mononuclear cell therapy system in Phase III clinical trial for the treatment of ischemic heart failure with reduced ejection fraction and refractory angina resulting from chronic myocardial ischemia. The company is also developing an allogeneic cells therapy platform, which is an investigational culture expanded bone marrow derived mesenchymal cell therapy in Phase I/II trial to treat ischemic heart failure and acute respiratory distress syndrome. In addition, it offers the Helix biotherapeutic delivery system for minimally invasive targeted delivery of biologic agents to the heart; and Morph deflectable guides and sheaths. The company has collaboration agreements with CellProthera in the development of ProtheraCytes, which is currently under Phase II trial for the treatment of acute myocardial infarction. BioCardia, Inc. is based in Sunnyvale, California.
Q&A For BioCardia Stock
What is a current BCDAW stock price?
BioCardia BCDAW stock price today per share is 0.0061 USD.
How to purchase BioCardia stock?
You can buy BCDAW shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BioCardia?
The stock symbol or ticker of BioCardia is BCDAW.
Which industry does the BioCardia company belong to?
The BioCardia industry is Biotechnology.
How many shares does BioCardia have in circulation?
The max supply of BioCardia shares is 0.
What is BioCardia Price to Earnings Ratio (PE Ratio)?
BioCardia PE Ratio is now.
What was BioCardia earnings per share over the trailing 12 months (TTM)?
BioCardia EPS is -3.2 USD over the trailing 12 months.
Which sector does the BioCardia company belong to?
The BioCardia sector is Healthcare.